Goldman has a new favorite biotech because of potential Alzheimer’s blockbuster
August 16, 2017 | Uncategorized
Goldman Sachs added biotech company Biogen to its Americas Conviction List, citing a 'blockbuster' drug.
Goldman Sachs added biotech company Biogen to its Americas Conviction List, citing a 'blockbuster' drug.
